Aeglea BioTherapeutics Inc is a clinical-stage biotechnology company developing human enzyme therapeutics to benefit people with rare metabolic diseases... Show more
Get AI intraday signals
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.